ADC Therapeutics News

ADC Therapeutics | 8-K: Current report

May 14 11:34

ADC Therapeutics | 8-K: Current report

May 8 16:27

ADC Therapeutics | 8-K: ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 6 05:33

ADC Therapeutics | DEF 14A: Definitive information statements

Apr 26 15:34

ADC Therapeutics | DEFA14A: Others

Apr 26 15:26

ADC Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 15:22

ADC Therapeutics | 8-K: Current report

Apr 9 15:12

ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 13 15:23

ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 13 15:21

ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 13 15:20

ADC Therapeutics | 8-K: ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Mar 13 06:43

ADC Therapeutics | 8-K: Current report

Mar 5 08:17

ADC Therapeutics | 8-K: Current report

Feb 29 15:34

ADC Therapeutics | 8-K: Current report

Jan 24 07:04

ADC Therapeutics | 8-K: Current report

Jan 18 23:00

ADC Therapeutics | 8-K: Current report

Jan 3 23:00

ADC Therapeutics | 8-K: Current report

Jan 3 23:00

ADC Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 19, 2023 06:00

ADC Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 18, 2023 15:25

ADC Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 4, 2023 15:57